United States · FDA National Drug Code directory

Divalproex Sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
62756-798_9fa8a32e-7def-4ae6-b537-15450ef34bc2
Product NDC
62756-798
Form
TABLET, DELAYED RELEASE
Composition / generic term
Divalproex Sodium
Labeler
Sun Pharmaceutical Industries, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20080729
Source listing expiry
20271231

Source-listed ingredients

  • DIVALPROEX SODIUM — 500 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET, DELAYED RELEASE in 1 BOTTLE (62756-798-08) · 62756-798-08
  • 500 TABLET, DELAYED RELEASE in 1 BOTTLE (62756-798-13) · 62756-798-13
  • 1000 TABLET, DELAYED RELEASE in 1 BOTTLE (62756-798-18) · 62756-798-18
  • 30 TABLET, DELAYED RELEASE in 1 BOTTLE (62756-798-83) · 62756-798-83
  • 100 TABLET, DELAYED RELEASE in 1 BOTTLE (62756-798-88) · 62756-798-88

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →